Novel Inhibitors of the MDM2-p53 Interaction Featuring Hydrogen Bond Acceptors as Carboxylic Acid Isosteres.
Gonzalez, A.Z., Li, Z., Beck, H.P., Canon, J., Chen, A., Chow, D., Duquette, J., Eksterowicz, J., Fox, B.M., Fu, J., Huang, X., Houze, J., Jin, L., Li, Y., Ling, Y., Lo, M.C., Long, A.M., McGee, L.R., McIntosh, J., Oliner, J.D., Osgood, T., Rew, Y., Saiki, A.Y., Shaffer, P., Wortman, S., Yakowec, P., Yan, X., Ye, Q., Yu, D., Zhao, X., Zhou, J., Olson, S.H., Sun, D., Medina, J.C.(2014) J Med Chem 57: 2963-2988
- PubMed: 24601644 
- DOI: 10.1021/jm401911v
- Primary Citation of Related Structures:  
4OCC, 4ODE, 4ODF, 4OGN, 4OGT, 4OGV - PubMed Abstract: 
We previously reported the discovery of potent and selective morpholinone and piperidinone inhibitors of the MDM2-p53 interaction. These inhibitors have in common a carboxylic acid moiety that engages in an electrostatic interaction with MDM2-His96. Our continued search for potent and diverse inhibitors led to the discovery of novel replacements for these acids uncovering new interactions with the MDM2 protein ...